Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Leukemia 10 Leukemia, Myeloid, Acute 7 Congenital Abnormalities 6 Glioblastoma 5 Lung Neoplasms 4 Leukemia, Myelomonocytic, Acute 4 Leukemia, Monocytic, Acute 4 Leukemia, Megakaryoblastic, Acute 4 Leukemia, Erythroblastic, Acute 4 Gliosarcoma 4 Colorectal Neoplasms 4 Central Nervous System Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Wilms Tumor 3 Uterine Cervical Neoplasms 3 Squamous Intraepithelial Lesions 3 Myelodysplastic Syndromes 3 Colonic Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Breast Neoplasms 3 Sarcoma 2 Rectal Neoplasms 2 Precancerous Conditions 2 Ovarian Neoplasms 2 Oligodendroglioma 2 Leukemia, Eosinophilic, Acute 2 Leukemia, Basophilic, Acute 2 Kidney Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Brain Neoplasms 2

Interventions

Cyclophosphamide 153 Dexamethasone 141 Rituximab 85 fludarabine 79 Lenalidomide 72 Cytarabine 70 Bortezomib 64 fludarabine phosphate 63 Gemcitabine 62 venetoclax 54 Etoposide 53 pomalidomide 52 pembrolizumab 52 Paclitaxel 48 Cisplatin 48 Carboplatin 48 Peripheral Blood Stem Cell Transplantation 47 Filgrastim 40 Radiotherapy 39 Busulfan 37 Calcium Dobesilate 36 Methotrexate 34 Melphalan 34 Bevacizumab 33 carfilzomib 32 Cyclosporine 32 Azacitidine 32 Mycophenolic Acid 30 Vincristine 29 Bendamustine Hydrochloride 29

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × DNA Methylation × Clear all

NCT05504772 2024-07-17

ZERO2

Australian & New Zealand Children's Haematology/Oncology Group

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡